Cooper Companies, Inc.
6140 Stoneridge Mall Road
51 articles with Cooper Companies, Inc.
CooperCompanies announced financial results for its fiscal second quarter ended April 30, 2021.
CooperCompanies announced that its Board of Directors has elected Dr. Maria Rivas as an independent director, effective July 1, 2021.
CooperCompanies, announced it will release second quarter 2021 financial results on Thursday, June 3, 2021, at 4:15 PM ET.
CooperCompanies Announces New Board AppointmentsRobert S. Weiss named Chairman of the Board and William A. Kozy named Vice Chairman and Lead Director
CooperCompanies announced that its Board of Directors elected Robert S. Weiss as Chairman of the Board and William A. Kozy as Vice Chairman and Lead Director. Both appointments are effective March 23, 2021.
CooperCompanies announced financial results for its fiscal first quarter ended January 31, 2021.
CooperCompanies, will participate in the KeyBanc Life Sciences MedTech Investor Forum on Wednesday, March 24, 2021.
CooperCompanies, announced that CooperSurgical has acquired Safe Obstetric Systems, a privately held manufacturer of the medical device, Fetal Pillow®.
CooperCompanies, will participate in the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021.
CooperCompanies, announced it will release first quarter 2021 financial results on Thursday, March 4, 2021, at 4:15 PM ET.
EssilorLuxottica and CooperCompanies, two of the world’s leading vision care companies, have entered into an agreement to create a 50/50 joint venture for the acquisition of SightGlass Vision, a U.S. based life sciences company focused on developing innovative spectacle lenses to reduce the progression of myopia in children.
CooperCompanies Awarded Great Place to Work® CertificationEmployees give company culture high marks for fairness, respect, and pride
For the third year in a row, CooperCompanies has been designated as Great Place to Work-Certified™ organization based on a detailed evaluation of workplace culture and the employee experience.
CooperCompanies, announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 9, 2021, to stockholders of record on January 22, 2021.
CooperCompanies, will present virtually at the J.P. Morgan Healthcare Conference on January 12, 2021. Al White, President and CEO, will represent the Company in a presentation scheduled to begin at 12:40PM PT.
CooperCompanies announced that it will hold its next annual meeting of stockholders on Wednesday, March 17, 2021.
CooperCompanies announced that A. Thomas Bender and Allan E. Rubenstein, M.D. have decided to retire and will not stand for re-election at the Annual Meeting of Stockholders in March 2021.
CooperCompanies announced financial results for its fiscal fourth quarter and full year ended October 31, 2020.
CooperCompanies announced that its Board of Directors elected Teresa S. Madden to the Board as an independent director, effective December 1, 2020.
CooperCompanies announced it will release fourth quarter and full year 2020 financial results on Thursday, December 3, 2020, at 4:15 PM ET.
CooperCompanies and Divisions Named One of Fortune’s Best Large Workplaces in Manufacturing and ProductionCooperCompanies, CooperVision and CooperSurgical All Recognized by Fortune Magazine
CooperCompanies announced that the company, along with its CooperVision and CooperSurgical divisions has been named one of Fortune's Best Large Workplaces in Manufacturing and Production.
CooperCompanies, will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference, on September 16, 2020.